Key statistics
On Monday, Dyne Therapeutics Inc (DYN:NSQ) closed at 8.91, 40.09% above the 52 week low of 6.36 set on Apr 09, 2025.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 8.64 |
---|---|
High | 9.27 |
Low | 8.64 |
Bid | 8.82 |
Offer | 9.12 |
Previous close | 8.64 |
Average volume | 4.03m |
---|---|
Shares outstanding | 137.88m |
Free float | 100.56m |
P/E (TTM) | -- |
Market cap | 1.19bn USD |
EPS (TTM) | -3.59 USD |
Data delayed at least 15 minutes, as of Jul 14 2025 21:00 BST.
More ▼
- Dyne Therapeutics Announces Closing of Public Offering of Common Stock and Full Exercise by Underwriters of Option to Purchase Additional Shares
- Dyne Therapeutics Announces Pricing of $200.0 Million Public Offering of Common Stock
- Dyne Therapeutics Announces Proposed Public Offering of Common Stock
- Dyne Therapeutics Secures Up to $275 Million in Debt Financing from Hercules Capital
- Dyne Therapeutics Announces FDA Breakthrough Therapy Designation for DYNE-101 and Updated Plan for Accelerated Approval in DM1 Following Type C Meeting
- Dyne Therapeutics to Host Investor Conference Call and Webcast to Provide Update on DYNE-101 for Myotonic Dystrophy Type 1, Tomorrow Tuesday, June 17 at 8:00 a.m. ET
- Dyne Therapeutics to Present New Preclinical Data in Facioscapulohumeral Muscular Dystrophy at the FSHD Society International Research Congress
- Dyne Therapeutics Reports First Quarter 2025 Financial Results and Recent Business Highlights
- Dyne Therapeutics Receives European Medicines Agency (EMA) Orphan Drug Designation for DYNE-251 in Duchenne Muscular Dystrophy
- Dyne Therapeutics Announces Chief Business Officer and Chief Scientific Officer Appointments
More ▼